Clinical Guidelines
Trends and Challenges in Nitrosamine Testing Part Four The Regulatory Landscape
-
April 17, 2026
-
6 min
April 17, 2026
The combination of the NECTIN4-directed antibody drug conjugate enfortumab vedotin-ejfv and the immunotherapy drug pembrolizumab is the established first-line standard-of-care treatment for patients w...
by Jo Cavallo
April 17, 2026
I am writing this from the hospital waiting room. My father is undergoing an 11-hour surgery to remove his parotid gland and a squamous cell carcinoma that has metastasized from his cheek and invaded ...
by ALISON RASH
April 15, 2026
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from March 16 - 31.